Pancreatic Cancer Research

ResearcherChangzhi Medical CollegeActive in the last 2 years

Huiqing Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9137-9671; OpenAlex author ID A5101905662. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Mutation on JmjC domain of UTX impaired its antitumor effects in pancreatic cancer via inhibiting G0S2 expression and activating the Toll-like signaling pathwa… Last author DOI 10.1186/s10020-024-01023-2↗
  2. circPTPN22 attenuates immune microenvironment of pancreatic cancer via STAT3 acetylation. Co-author DOI 10.1038/s41417-021-00382-w↗
  3. A novel lncRNA PTTG3P/miR-132/212-3p/FoxM1 feedback loop facilitates tumorigenesis and metastasis of pancreatic cancer. Co-author DOI 10.1038/s41420-020-00360-5↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiao-hua Shen · 1 shared paper, 2024 · strength 0.26
  2. Yuan He · 1 shared paper, 2023 · strength 0.18
  3. Chuang Chen · 1 shared paper, 2023 · strength 0.18
  4. Changhong Lian · 1 shared paper, 2023 · strength 0.18
  5. Hao Hu · 1 shared paper, 2023 · strength 0.18
  6. Wenyu Liu · 1 shared paper, 2020 · strength 0.11
  7. Xiangyu Kong · 1 shared paper, 2020 · strength 0.11
  8. Zhaoshen Li · 1 shared paper, 2020 · strength 0.11
  9. Huiyun Zhu · 1 shared paper, 2020 · strength 0.11
  10. Fanyang Kong · 1 shared paper, 2020 · strength 0.11
  11. Kaixuan Wang · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.